DPA Order May Be Used To Help Pfizer Supply US With 100M More Vaccine Doses

Five doses of Pfizer's COVID-19 vaccine that received emergency use authorization are seen before they are distributed to doctors and nurses at George Washington University Hospital on December 14, 2020 in Washington... Five doses of Pfizer's COVID-19 vaccine that received emergency use authorization are seen before they are distributed to doctors and nurses at George Washington University Hospital on December 14, 2020 in Washington, DC. (Photo by Jacquelyn Martin-Pool/Getty Images) MORE LESS
Start your day with TPM.
Sign up for the Morning Memo newsletter

WASHINGTON (AP) — Pfizer said Wednesday it will supply the U.S. government with an additional 100 million doses of its COVID-19 vaccine under a new agreement between the pharmaceutical giant and the Trump administration.

Pfizer and its partner BioNTech said that will bring their total current commitment to 200 million doses for the U.S. That should be enough to vaccinate 100 million people with the two-shot regimen. The government also has an option to purchase an additional 400 million doses.

“This new federal purchase can give Americans even more confidence that we will have enough supply to vaccinate every American who wants it by June 2021,” said Health and Human Services Secretary Alex Azar in a statement. The cost to taxpayers: $1.95 billion for the additional 100 million doses.

A senior administration official, speaking on condition of anonymity to discuss details of the agreement, said it involves the government using its authority under a Cold War-era law to help safely expand output of the vaccine and accelerate production.

Pfizer’s vaccine was the first to be approved for emergency use by the Food and Drug Administration. It has now been joined by another two-shot vaccine from Moderna, developed in close collaboration with the National Institutes of Health. The government began shipping the Pfizer vaccine to states last week, and the one from Moderna this week.

The priority groups for first vaccination include health care workers and nursing home residents. Gradually more Americans will have access to the free vaccines, which have been shown to be highly effective in clinical studies undertaken so far.

Separately, HHS announced it has joined forces with another big pharma company — Merck— to support the large-scale manufacture of a promising treatment for patients suffering from severe COVID-19 illness.

The treatment, still under investigation and not yet approved by the FDA, is known as MK-7110. It has the potential to minimize the damaging effects of an overactive immune response to COVID-19. This immune overdrive unleashes a cascade of effects on the human body, complicating the life-saving efforts of doctors and nurses.

The government is paying Merck about $356 million to fast-track production of its treatment under the auspices of Operation Warp Speed, a joint effort between HHS, the Pentagon, and drug companies to develop vaccines and treatments. It’s the same collaboration that led to Moderna’s vaccine. The money will allow Merck to deliver up to 100,000 doses by June 30, if the FDA clears the treatment for emergency use. Hospitals are under strain in California and other states, as the current wave of COVID-19 threatens to overwhelm their capacity to treat more patients.

Under the Pfizer deal announced Wednesday, the company will deliver at least 70 million of the additional vaccine doses purchased by June 30, with the remaining 30 million to be delivered no later than July 31.

“With these 100 million additional doses, the United States will be able to protect more individuals and hopefully end this devastating pandemic more quickly,” Pfizer CEO Albert Bourla said in a statement. “We look forward to continuing our work with the U.S. government and healthcare providers around the country.”

Pfizer initially had a contract through Operation Warp Speed to supply the government with 100 million doses of its vaccine. The drugmaker will receive nearly $2 billion for that deal as well.

The Associated Press previously reported that the government was close to reaching the just-announced deal with Pfizer in exchange for helping the company gain better access to manufacturing supplies.

A law dating back to the Korean War gives the government authority to direct private companies to produce critical goods in times of national emergency. Called the Defense Production Act, it’s expected to help Pfizer secure some raw materials needed for its vaccine.

The vaccine from Pfizer and German pharmaceutical BioNTech immediately raised hopes of taming a pandemic that has killed nearly 320,000 people in the U.S. and hobbled much of the national economy. Local TV stations across the country began broadcasting scenes of doctors and nurses garbed in hospital scrubs receiving the first vaccinations. Some polls show skepticism about getting vaccinated may be easing.

After early failures with testing, Trump administration officials are hoping to write a very different ending with vaccines. Operation Warp Speed has financed the development, manufacture and distribution of millions of doses, with the goal of providing a free vaccine to any American who wants one.

Operation Warp Speed is on track to have about 40 million doses of vaccine by the end of this month, of which about 20 million would be allocated for first vaccinations. Distribution of those doses would span into the first week of January. Both the Pfizer and Moderna vaccines require two shots to be fully effective.

___

Associated Press writer Jonathan Lemire contributed to this report.

Latest News

Notable Replies

  1. What is the Trump Org’s commission?

  2. Soon we’ll be reading stories about all the Trump connected middlemen in the chain of vaccine distribution that are raking in huge no-bid money on various contracts.

  3. How does delivery of 70 million doses by June 30, with the remaining 30 million no later than July 31, i.e. enough to vaccinate 50 million people, translate into "enough supply to vaccinate every American who wants it by June 2021”?

  4. Remember, folks, Azar is a liar, liar, pants on fire.

  5. As the pandemic absolutely rages now, I personally know many people who have contracted this and several who have died. My wife’s best friend’s daughter is having an alarming hospital course in MI - she is 27, and though she is finally breathing better her blood work is strangely out of whack. She seems to be experiencing some of the less common but equally devastating effects of COVID that cause erratic blood clotting and have caused some people to have amputations. So far her limbs seem OK but she threw a large pulmonary clot which is slowly being dissolved by heavy duty anti-coagulation and time. No miracle monoclonal antibodies for her. She is just a nobody who has been working as a social worker in a group home for the last 9 months, actually living there to observe the best possible way to not bring in the virus from the outside. Definitely not a celebrity.

    Thank God competent people are about to take over. Every delay in getting the vaccine out and administered will be reflected in a thousand more deaths of the non-celebrities among us.

Continue the discussion at forums.talkingpointsmemo.com

1 more reply

Participants

Avatar for discobot Avatar for steviedee111 Avatar for birdford Avatar for coimmigrant Avatar for txlawyer Avatar for Hatmama

Continue Discussion
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Deputy Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: